Cardinal Health stock is being upgraded to a buy rating, from my prior hold rating last year, agreeing with the SA analyst consensus today. Bullish drivers include recent revenue/earnings growth, ...

Feb 1 (Reuters) - Cardinal Health (CAH.N), opens new tab lowered the full-year profit forecast for its medical segment on Thursday, taking the shine off the company's upbeat second-quarter results and ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Cardinal Health (CAH) been one of those stocks this year? A quick glance at the ...

The Cordis medical device business that Cardinal Health bought for $1.9 billion is proving to be a millstone for the company. Cordis, a former Johnson & Johnson subsidiary, ran into a raft of ...

In the latest close session, Cardinal Health (CAH) was up +1.93% at $202.95. The stock's performance was ahead of the S&P 500's daily gain of 0.88%. Meanwhile, the Dow gained 0.38%, and the Nasdaq, a ...

Cardinal Health, which manufactures and distributes medical and laboratory products, has entered into a definitive agreement to acquire Integrated Oncology Network, a physician-led independent ...

Cardinal Health shared its plans to open a new distribution center in Walton Hills, Ohio, supporting its U.S. Medical Products and Distribution business. The facility will integrate new technology ...

Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy ...

The drug and medical products distributor Cardinal Health plans to acquire Medtronic's medical supplies business for $6.1 billion, the company announced on Tuesday. The cash deal would give the Dublin ...

DUBLIN, Ohio, Feb. 9, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced it will leverage the Kinaxis® RapidResponse® platform to increase medical product visibility and supply chain ...

Cardinal Health has no plans to sell its medical supply division despite ongoing struggles, this time due to inflation, CEO Mike Kaufmann said. Here's how Cardinal ...

Drug distributor Cardinal Health Inc said on Friday it would sell its Cordis medical device business to private equity firm Hellman & Friedman in a deal valued at about $1 billion. Updates with ...